ILF2 and neoplasm: Silencing ILF2 expression in PDAC inhibited cell cycle progression and decreased the expression of cell cycle regulators like cyclin E1 (CCNE) and proliferating cell nuclear antigen (PCNA), hindering tumor cell proliferation (12).